For the second time this year, the U.S. Supreme Court has refused to hear a challenge by Johnson & Johnson in litigation over its talcum powder products, which women have claimed cause ovarian cancer.
In Johnson & Johnson v. Fitch, the company challenged a Mississippi Supreme Court decision that a state consumer protection law required an ovarian cancer warning label even though the U.S. Food and Drug Administration had concluded earlier that evidence did not justify a warning, according to J&J counsel E. Joshua Rosenkranz of Orrick Herrington & Sutcliffe.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]